Why the study?
Ectopic fat is increasingly recognized as a heterogeneous, metabolically active contributor to obesity-related cardiometabolic disorders with clinical implications beyond conventional measures of adiposity, warranting a synthesis of evidence on its depot-specific biology and therapeutic implications.
Design
Narrative review
Answers are grounded in this paper and cite their sources.
Ectopic fat assessment may refine cardiometabolic risk stratification beyond BMI; leaves open targeted therapies pending prospective trials.
Ectopic fat is increasingly recognized as a heterogeneous, metabolically active contributor to obesity-related cardiometabolic disorders, with clinical implications extending beyond conventional measures of adiposity. This narrative review synthesizes experimental, translational, and clinical evidence on the mechanisms of ectopic fat accumulation, depot-specific biological characteristics, clinical significance, and therapeutic implications. Impaired subcutaneous adipose tissue expandability and lipid buffering capacity promote ectopic lipid deposition, contributing to lipotoxicity, inflammation, oxidative stress, mitochondrial dysfunction, fibrosis, and impaired insulin signaling. Despite shared pathogenic mechanisms, individual depots exhibit distinct organ-specific associations. Epicardial, pericardial, and perivascular fat are implicated in cardiovascular dysfunction; hepatic fat is closely associated with metabolic dysfunction-associated steatotic liver disease and insulin resistance; pancreatic fat may contribute to β-cell dysfunction; skeletal muscle fat is linked to metabolic and functional impairment; and perirenal and renal sinus fat are implicated in renal dysfunction and alterations in cardiovascular structure and function. Advanced imaging enables depot-specific quantification and characterization of ectopic fat, providing information beyond conventional measures of adiposity. Lifestyle modifications and pharmacological therapies may reduce ectopic fat accumulation in selected depots, although their effects vary across organs and interventions. Collectively, these findings highlight ectopic adiposity as a potentially modifiable component of obesity-related cardiometabolic complications. Integrating imaging-based assessment with molecular phenotyping may improve understanding and assessment of obesity-related organ dysfunction.
No takes yet. Share an insight, caveat, or question.
Gruszczyński et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: